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Background. Pseudomonas aeruginosa is an important life-
threatening nosocomial pathogen which plays a prominent role in 
wound infections in burns patients. We designed this study to iden-
tify the isolates of P. aeruginosa recovered from burns patients at 
the genus and species levels by means of primers targeting oprI 
and oprL genes.
Methods. During a 5-month period, wound samples were taken 
from burns patients and plated on MacConkey agar. All suspected 
colonies were screened for P. aeruginosa by means of a combina-
tion of phenotype tests. Specific primers for oprI and oprL genes 
were then used for the molecular identification of colonies. 
Results. During the 5-month period, bacterial isolates recovered 
from burn wound infections were analyzed. Phenotype identifica-
tion tests identified 171 (34.8%) P. aeruginosa isolates. However, 
molecular techniques that used species-specific primers to detect 
the amplicon of the oprL gene confirmed the exact identification 
of P. aeruginosa in only 133 cases; in the other isolates, the use 
of genus-specific primers detected the amplicon of the oprI gene, 
which confirmed the identification of fluorescent pseudomonads. 
Conclusions. This study indicates that molecular detection by 
means of an assay targeting the oprL gene is a useful technique for 
the rapid and precise detection of P. aeruginosa in burns patients. 
In addition to phenotype testing, PCR detection should be carried 
out in order to promptly ascertain the best aggressive antibiotic 
therapy for P. aeruginosa infections, thereby significantly improv-
ing clinical outcomes.
Original article
PCR-based assay for the rapid and precise distinction 
of Pseudomonas aeruginosa from other Pseudomonas 
species recovered from burns patients 
A. GHOLAMI1, A. MAJIDPOUR2, M. TALEBI-TAHER2, M. BOUSTANSHENAS2, M. ADABI2
1 Department of Internal Medicine, Rasoul-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran; 2 Antimicrobial 
Resistance Research Center, Rasoul-Akram hospital, Iran University of Medical Sciences, Tehran, Iran 
Keywords
Pseudomonas aeruginosa • Burns patients • OprL, OprI
Summary
Introduction
Burn injury, one of the most common and devastat-
ing forms of trauma, is a major public health problem 
worldwide. Burn wounds can easily become infected 
because the skin no longer acts as an effective physi-
cal barrier against microbes. P. aeruginosa is the most 
common source of burn wound infections  [1]. While 
these bacteria rarely cause disease in healthy individu-
als, they may do so in immuno compromised patients, 
such as those with AIDS or cystic fibrosis, and in burns 
patients [2]. The accurate identification of P. aeruginosa 
and detection of their susceptibility to antimicrobials are 
critical components of the management of burned pa-
tient. P. aeruginosa colonisation is normally detected 
by culturing wound swabs on artificial media. Typical 
isolation media used in wound infections include blood 
agar and chocolate agar and selective agars such as Mac-
Conkey agar and cetrimide-based media. Although large 
numbers of P. aeruginosa isolates are often present in 
clinical samples from burns patients, their detection and 
precise identification can often be challenging. For ex-
ample, other species of Pseudomonas, as well as Steno-
trophomonas maltophilia, Achromobacter xylosoxidans 
and Ralstonia pickettii, have been shown to grow on ce-
trimide-based media  [3], and may be indistinguishable 
from non-pigmented strains of P. aeruginosa. Difficul-
ties in recognizing P. aeruginosa are compounded by 
difficulties in biochemical identification. Biochemical 
test kits such as API 20 NE are commonly used for iden-
tification [4]; however, this technique has been seen to 
display a high rate of misidentification of oxidase-posi-
tive Gram-negative rods, including P. aeruginosa [5]. In 
addition, testing requires the use of a pure bacterial sub-
culture and a minimum incubation time of 48 h. Hence, 
identification by means of this method requires at least 
3  days. Another limitation of the conventional culture 
technique is that P. aeruginosa can easily be mistaken 
for closely related Gram-negative bacilli. The use of mo-
lecular techniques such as PCR could enable accurate 
and rapid identification of P. aeruginosa [6, 7]. L and I 
lipoproteins are two outer membrane proteins of P. ae-
ruginosa, and are responsible for the inherent resistance 
of the bacterium to antibiotics and antiseptics. As these 
proteins are found only in this organism, they could be 
used as a reliable marker for the rapid identification of 
P. aeruginosa in clinical samples  [8,  9]. In this study, 
we examined a technique for the rapid and precise iden-
tification of P. aeruginosa strains isolated from burns 
patients hospitalized in a main burns center in Iran. The 
performance of this technique, which utilizes PCR am-
plification of I lipoprotein (OprI) to detect the genus and 
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L lipoprotein (OprL) to detectthe species of P. aerugi-
nosa strains, was compared with that of phenotypic and 
routine biochemical identification used in laboratories. 
Materials and methods
Qualitative conventional detection
This study was carried out during a 5-month period, at 
a major center for the admission of burns patients in 
Tehran, Iran. Samples were obtained from burn wounds 
by swabbing. As in the routine phonotype tests usually 
performed in clinical laboratories, we inoculated burn 
wound swabs onto several selective media for the isola-
tion of P. aeruginosa, including blood agar, MacConkey 
agar and Muller Hinton agar, and carried out incubation 
at 37ºC for 24-48  h. The isolates were presumptively 
identified by means of routine tests: colony morphology 
and pigment formation on selective medium, positive 
oxidase test, glucose fermentation, hydrolysis of gelatin 
and growth at 42ºC [10, 11]. 
Molecular (PCR) detection
DNA extraction. In order to minimize contamination 
and hence the possibility of false-positive results, all 
DNA isolation procedures were carried out in a room 
physically separated both from that used to set up nu-
cleic acid amplification reaction mixtures and from the 
post-PCR room. Bacterial genomic DNA was extracted 
from all phenotypically and biochemically tested strains, 
as well as from the reference strain P. aeruginosa ATCC 
27853, by means of a boiling method. For this purpose, 
depending on colony size, three to six colonies were 
picked from bacterial plates and mixed into 0.25  ml 
DNase/RNase-free water in sterile 1.5  ml eppendorf 
tubes in order to obtain a turbid suspension of bacteria 
(~ 1-2 × 109 cells/ml). The cell suspensions were kept in 
a boiling water bath for 10 minutes to lyse the cells, and 
were then centrifuged at 10000 g at 4°C for 10 minutes. 
Finally, the supernatant was transferred, in sterile condi-
tions, into another tube and used as a DNA template. 
Extracted DNA was stored at -20°C prior to PCR ampli-
fication [12].
Primer selection. The primers used in this study are 
shown in Table  I. PCR amplification of I lipoprotein 
(OprI) for the detection of Pseudomonas genus and L li-
poprotein (OprL) for the detection of P. aeruginosa spe-
cies was performed on all phenotypically tested strains 
of P. aeruginosa.
PCR amplification. In order to minimize contamina-
tion, all reaction mixtures were set up in a PCR room 
separate from that used for DNA extraction and amplifi-
cation and from the post-PCR room. PCR was complet-
ed in adapted PCR micro centrifuge tubes according to 
the thermocycler used. Following optimization, reaction 
mixtures (25 μl) were set up as follows: 11 μl DNase/
RNase-free water, 8  μl 2x PCR Master Mix (1.5  mM 
mgcl2, Denmark), 0.5 μl of each set of primers (OprL or 
OprI) and 5 μl of DNA template. The reaction mixtures 
were subjected to the following empirically optimized 
thermal cycling parameters in a thermocycler (Senso-
Quest Labcycler, Germany): 94°C for 5 min, followed 
by 30 cycles of 94°C for 1 min, 55°C for 1 min, 72°C 
for 1 min, and a final extension at 72°C for 10 min. Posi-
tive (P. aeruginosa ATCC 27853 DNA) and multiple 
negative (water) amplification controls were included in 
every set of PCR reactions.
Detection of amplicons
Following amplification, aliquots (10 μl) were removed 
from each reaction mixture and examined by means of 
electrophoresis (80 V, 45 min) in gels composed of 1% 
agarose in TBE buffer (40 mM Tris, 20 mM boric ac-
id, 1 mM EDTA, pH 8.3). Gels were visualized under 
UV illumination by using a gel image analysis system 
(UVitec, Cambridge, United Kingdom) and all images 
were archived. Where a band was visualized at the cor-
rect expected size for OprI, the specimen was considered 
positive for Pseudomonas genus; if a band was visual-
ized at the correct expected size for OprL loci, the speci-
men was considered positive for P. aeruginosa species.
Results
During the 5-month period, 491 bacterial samples re-
covered from burn wound infections were analyzed. 
The above-mentioned routine phenotype and biochemi-
cal tests enabled P. aeruginosa isolates to be recovered 
from 171 (34.8%) patients. By contrast, molecular tech-
niques detected only 133 (27.08%) samples positive for 
P. aeruginosa species and 38 (7.73%) samples positive 
for pseudomonas genus. PCR assays employing each 
primer pair yielded DNA products of the predicted sizes 
(Fig. 1 and 2). The OprI and OprL amplicon genes were 
detected in all 133 P. aeruginosa isolates simultane-
ously. Table II shows the comparison of phenotype and 
biochemical testing with the molecular detection of P. 
aeruginosa in samples from burn wound infections.
Tab. I. Primers used in this study.
Primer 5’-sequence-3’ Product length (bp) Reference
OprI-F ATGAACAACGTTCTGAAATTCTCTGCT
249 7
OprI-R CTTGCGGCTGGCTTTTTCCAG
OprL-F
OprL-R
ATGGAAATGCTGAAATTCGGC
CTTCTTCAGCTCGACGCGACG
504 7
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Discussion
Bacterial infections in burn wounds are common and 
are difficult to control. In recent decades, following the 
introduction of antibiotic therapy, P. aeruginosa has 
emerged as one of the most problematic Gram-negative 
bacteria in modern hospital settings. This organism is in-
creasingly isolated as a nosocomial pathogen, and is re-
sponsible for high morbidity and mortality rates in burns 
patients, mechanically ventilated patients and those with 
cystic fibrosis [13, 14]. Infection by this bacterium is par-
ticularly problematic, since the organism is intrinsically 
Fig. 1. PCR amplification using Pseudomonas genus-specific primers (Opr I gene), M: marker, line 1: positive control, lines 2, 3, 4: clinical 
isolates of Pseudomonas genus, line 5: negative control.
Fig. 2. PCR amplification using P. aeruginosa-specific primers (Opr L gene), M: marker, line 1: positive control, lines 2, 3, 4, 5, 6: clinical iso-
lates of P. aeruginosa, line 7: negative control.
Tab. II. Comparison of phenotype and biochemical tests with molecular detection of P. aeruginosa in samples from burn wound infections.
Phenotypically & biochemically +
(no. of isolates tested)
PCR(OprI)+
no. of isolates 
PCR(OprL)+
no. of isolates 
171 171 133
Biochemical method+: strains confirmed as P. aeruginosa on phenotype and biochemical testing.
PCR (OprI)+: strains confirmed as Pseudomonas genus by PCR amplification of OprI.
PCR (OprL)+: strains confirmed as P. aeruginosa genus by PCR amplification of OprL.
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resistant to many drug classes and is able to acquire re-
sistance to all effective antimicrobial drugs. Some stud-
ies carried out in Iran have also indicated that infections 
caused by multi-drug resistant (MDR) P. aeruginosa 
are widespread in Iranian hospitals [15, 16]. It is there-
fore important to identify P. aeruginosa accurately and 
rapidly and to ascertain the susceptibility pattern of this 
organism; this may avoid prolonged and sometimes un-
necessary antibiotic treatments, which could select other 
antibiotic-resistant pathogens [12]. The identification of 
P. aeruginosa has traditionally relied on phenotypic and 
biochemical methods. These tests take a long time to 
perform and require extensive hands-on work by techni-
cians, both for setup and for ongoing evaluation. Various 
methods have been developed to identify P. aeruginosa 
species rapidly and accurately. According to our litera-
ture review, PCR has the potential to identify microbial 
species rapidly and precisely through the amplification 
of gene sequences unique to a particular organism [17]. 
Indeed, several PCR-based, DNA probe methods have 
been developed to detect various pathogens in clinical 
samples and water and food samples  [18]. Also in the 
case of P. aeruginosa, molecular methods have been re-
ported to be superior to phenotypic methods in identi-
fying P. aeruginosa species  [19]. The outer membrane 
proteins of P. aeruginosa play important roles in the 
interaction of the bacterium with the environment [20]. 
In the present study, two PCR assays were performed 
individually for the molecular detection of two outer 
membrane lipoprotein genes, oprI and oprL, in samples 
from burn wounds [21]. According to the phenotype and 
biochemical tests carried out in this study, 171 (34.82%) 
of 491 bacterial samples recovered were classified as P. 
aeruginosa. However, while the results of our molecu-
lar tests on oprI and oprL genes confirmed that many 
of these isolatesbelonged to the pseudomonas genus, 
only 133  (77.7%) of them were confirmed as P. aeru-
ginosa species. Thus, there was nearly complete agree-
ment between molecular and conventional phenotype 
and biochemical detection techniques with regard to 
the attribution of the Pseudomonas genus, but not the P. 
aeruginosa species. This may account for the potential 
phenotype misidentification of P. aeruginosa which has 
been recently described  [22]. Alternatively, discrepant 
results (PCR- /biochemical+) may emerge in the case of 
true P. aeruginosa colonization, in that a false negative 
culture result may be due to sample overgrowth by other 
bacteria, or to the presence of non-cultivable organisms 
or auxotrophic mutations of the organism. Indeed, it has 
been shown that oprI is conserved among members of 
fluorescent pseudomonads  [23,  24]. De Vos et al. de-
signed a multiplex PCR assay based on oprI and oprL 
genes for the molecular detection of P. aeruginosa, and 
showed that its specificity and sensitivity were 74 and 
100%, respectively  [7]. Lavenir et al. also noted that 
all 268 of the P. aeruginosa strains that they detected 
contained the oprI and oprL genes (sensitivity = 100%, 
specificity = 80%) [25]. This is in line with our findings. 
Although our PCR and DNA sequence analyses revealed 
some isolates that had been misidentified by phenotype 
testing, it must be said that our study was not designed 
to ascertain the frequency of misidentification of isolates 
from burn wound infections or to compare the relative 
accuracy of different phenotype identification systems. 
The isolates analyzed in this study constituted a biased 
set of atypical isolates that were difficult to identify. 
Nevertheless, these isolates were well suited to provid-
ing a rigorous test of our PCR assays and represented 
strains for which molecular analysis would be expected 
to be most useful. Our study also confirms that various 
non-aeruginosa pseudomonal species can occasionally 
be recovered from burn wound infection cultures. In this 
regard, genotype-based identification methods circum-
vent the problem of phenotype variation and provide 
more accurate species identification. 
Conclusions
It is important that primary diagnostic bacteriology 
methods have the ability to detect transient and early 
Pseudomonas colonization in burns patients as soon as 
possible, so that: (i) aggressive antibiotic regimes may 
be reconsidered; (ii) the patient can be managed opti-
mally, with a view to avoiding early biofilm formation 
and chronic colonization with P. aeruginosa, and (iii) 
appropriate infection control precautions can be taken.
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